These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


208 related items for PubMed ID: 12226745

  • 1. p42/p44 MAPKs are intracellular targets of the CDK inhibitor purvalanol.
    Knockaert M, Lenormand P, Gray N, Schultz P, Pouysségur J, Meijer L.
    Oncogene; 2002 Sep 19; 21(42):6413-24. PubMed ID: 12226745
    [Abstract] [Full Text] [Related]

  • 2. Inducible expression of a MAP kinase phosphatase-3-GFP chimera specifically blunts fibroblast growth and ras-dependent tumor formation in nude mice.
    Marchetti S, Gimond C, Roux D, Gothié E, Pouysségur J, Pagès G.
    J Cell Physiol; 2004 Jun 19; 199(3):441-50. PubMed ID: 15095291
    [Abstract] [Full Text] [Related]

  • 3. Repression of mitogen-activated protein kinase (MAPK) phosphatase-1 by anthracyclines contributes to their antiapoptotic activation of p44/42-MAPK.
    Small GW, Somasundaram S, Moore DT, Shi YY, Orlowski RZ.
    J Pharmacol Exp Ther; 2003 Dec 19; 307(3):861-9. PubMed ID: 14557375
    [Abstract] [Full Text] [Related]

  • 4. Sphingosine-1-phosphate induces COX-2 expression via PI3K/Akt and p42/p44 MAPK pathways in rat vascular smooth muscle cells.
    Hsieh HL, Wu CB, Sun CC, Liao CH, Lau YT, Yang CM.
    J Cell Physiol; 2006 Jun 19; 207(3):757-66. PubMed ID: 16508949
    [Abstract] [Full Text] [Related]

  • 5. Inhibitory effect of antisense oligodeoxynucleotide to p44/p42 MAPK on angiotensin II-induced hypertrophic response in cultured neonatal rat cardiac myocyte.
    Zhang SQ, Ding B, Guo ZG, Li YX.
    Acta Pharmacol Sin; 2004 Jan 19; 25(1):41-6. PubMed ID: 14704121
    [Abstract] [Full Text] [Related]

  • 6. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
    Takada Y, Ichikawa H, Pataer A, Swisher S, Aggarwal BB.
    Oncogene; 2007 Feb 22; 26(8):1201-12. PubMed ID: 16924232
    [Abstract] [Full Text] [Related]

  • 7. Interleukin-1beta induces MMP-9 expression via p42/p44 MAPK, p38 MAPK, JNK, and nuclear factor-kappaB signaling pathways in human tracheal smooth muscle cells.
    Liang KC, Lee CW, Lin WN, Lin CC, Wu CB, Luo SF, Yang CM.
    J Cell Physiol; 2007 Jun 22; 211(3):759-70. PubMed ID: 17311279
    [Abstract] [Full Text] [Related]

  • 8. Extracellular cysteine/cystine redox regulates the p44/p42 MAPK pathway by metalloproteinase-dependent epidermal growth factor receptor signaling.
    Nkabyo YS, Go YM, Ziegler TR, Jones DP.
    Am J Physiol Gastrointest Liver Physiol; 2005 Jul 22; 289(1):G70-8. PubMed ID: 15746213
    [Abstract] [Full Text] [Related]

  • 9. The thyrotropin receptor is not involved in the activation of p42/p44 mitogen-activated protein kinases by thyrotropin preparations in Chinese hamster ovary cells expressing the human thyrotropin receptor.
    Corrèze C, Blondeau JP, Pomerance M.
    Thyroid; 2000 Sep 22; 10(9):747-52. PubMed ID: 11041451
    [Abstract] [Full Text] [Related]

  • 10. Thyroid hormones regulate DNA-synthesis and cell-cycle proteins by activation of PKCalpha and p42/44 MAPK in chick embryo hepatocytes.
    Alisi A, Spagnuolo S, Napoletano S, Spaziani A, Leoni S.
    J Cell Physiol; 2004 Nov 22; 201(2):259-65. PubMed ID: 15334660
    [Abstract] [Full Text] [Related]

  • 11. Involvement of MAPKs and NF-kappaB in LPS-induced VCAM-1 expression in human tracheal smooth muscle cells.
    Lin WN, Luo SF, Lee CW, Wang CC, Wang JS, Yang CM.
    Cell Signal; 2007 Jun 22; 19(6):1258-67. PubMed ID: 17303384
    [Abstract] [Full Text] [Related]

  • 12. IL-1 beta promotes A549 cell migration via MAPKs/AP-1- and NF-kappaB-dependent matrix metalloproteinase-9 expression.
    Lin CC, Kuo CT, Cheng CY, Wu CY, Lee CW, Hsieh HL, Lee IT, Yang CM.
    Cell Signal; 2009 Nov 22; 21(11):1652-62. PubMed ID: 19616091
    [Abstract] [Full Text] [Related]

  • 13. Tumor necrosis factor-alpha induces MMP-9 expression via p42/p44 MAPK, JNK, and nuclear factor-kappaB in A549 cells.
    Lin CC, Tseng HW, Hsieh HL, Lee CW, Wu CY, Cheng CY, Yang CM.
    Toxicol Appl Pharmacol; 2008 Jun 15; 229(3):386-98. PubMed ID: 18336852
    [Abstract] [Full Text] [Related]

  • 14. Involvement of p42/p44 MAPK, JNK, and NF-kappaB in IL-1beta-induced ICAM-1 expression in human pulmonary epithelial cells.
    Lin FS, Lin CC, Chien CS, Luo SF, Yang CM.
    J Cell Physiol; 2005 Feb 15; 202(2):464-73. PubMed ID: 15389584
    [Abstract] [Full Text] [Related]

  • 15. BK-induced COX-2 expression via PKC-delta-dependent activation of p42/p44 MAPK and NF-kappaB in astrocytes.
    Hsieh HL, Wang HH, Wu CY, Jou MJ, Yen MH, Parker P, Yang CM.
    Cell Signal; 2007 Feb 15; 19(2):330-40. PubMed ID: 16935468
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors.
    Chang YT, Gray NS, Rosania GR, Sutherlin DP, Kwon S, Norman TC, Sarohia R, Leost M, Meijer L, Schultz PG.
    Chem Biol; 1999 Jun 15; 6(6):361-75. PubMed ID: 10375538
    [Abstract] [Full Text] [Related]

  • 17. Regulation of p42/p44 MAPK and p38 MAPK by the adenosine A(1) receptor in DDT(1)MF-2 cells.
    Robinson AJ, Dickenson JM.
    Eur J Pharmacol; 2001 Feb 16; 413(2-3):151-61. PubMed ID: 11226388
    [Abstract] [Full Text] [Related]

  • 18. Role of Ras in ethanol modulation of angiotensin II activated p42/p44 MAP kinase in rat hepatocytes.
    Park PH, Aroor AR, Shukla SD.
    Life Sci; 2006 Nov 17; 79(25):2357-63. PubMed ID: 16950409
    [Abstract] [Full Text] [Related]

  • 19. TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways.
    Rivas MA, Carnevale RP, Proietti CJ, Rosemblit C, Beguelin W, Salatino M, Charreau EH, Frahm I, Sapia S, Brouckaert P, Elizalde PV, Schillaci R.
    Exp Cell Res; 2008 Feb 01; 314(3):509-29. PubMed ID: 18061162
    [Abstract] [Full Text] [Related]

  • 20. Molecular mechanism of cell cycle blockage of hepatoma SK-Hep-1 cells by Epimedin C through suppression of mitogen-activated protein kinase activation and increased expression of CDK inhibitors p21(Cip1) and p27(Kip1).
    Liu TZ, Chen CY, Yiin SJ, Chen CH, Cheng JT, Shih MK, Wang YS, Chern CL.
    Food Chem Toxicol; 2006 Feb 01; 44(2):227-35. PubMed ID: 16112786
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.